Exacerbation of antimicrobial resistance: another casualty of the COVID-19 pandemic?
Mohammed S. Razzaque
Abstract
: Future studies that aim to generate clinically useful quorum quenching agents need to be considered. An important benefit of such agents may be a diminished risk of antimicrobial resistance.
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ExacerbationResistance (ecology)MedicineAntibiotic resistanceAntimicrobialVirologyIntensive care medicineMedical emergencyInfectious disease (medical specialty)ImmunologyMicrobiologyBiologyAntibioticsDiseaseOutbreakInternal medicineEcologyAntibiotic Use and ResistanceCOVID-19 Clinical Research StudiesNosocomial Infections in ICU